The results of isolated hyperthermic limb perfusion in a multimodality therapy concept for soft-tissue sarcoma;Ergebnisse der isolierten hyperthermen extremitätenperfusion bei weichteilsarkomen im rahmen eines multimodalen behandlungskonzeptes

Chirurg

Volumn 67, Issue 12, 1996, Pages 1237-1243

  Schwarzbach, M ^a,c   Lehnert, Th ^b   Willeke, F ^a   Hinz, U ^b   Herfarth, Ch ^a  

^a Chirurgische Klinik und Poliklinik

^b UNIVERSITY OF HEIDELBERG   (Germany)

^c UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

Author keywords

Isolated hyperthermic limb perfusion; Limb sparing surgery; Soft tissue sarcoma

Indexed keywords

ANTINEOPLASTIC AGENT; CISPLATIN; DOXORUBICIN; MELPHALAN;

ADULT; AGED; ARTICLE; CANCER STAGING; DISEASE FREE SURVIVAL; FEMALE; HUMAN; HYPERTHERMIC THERAPY; LIMB; MALE; MIDDLE AGED; MORTALITY; MULTIMODALITY CANCER THERAPY; PATHOLOGY; REGIONAL PERFUSION; SARCOMA; SOFT TISSUE TUMOR; SURVIVAL RATE; TUMOR RECURRENCE;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHEMOTHERAPY, CANCER, REGIONAL PERFUSION; CISPLATIN; COMBINED MODALITY THERAPY; DISEASE-FREE SURVIVAL; DOXORUBICIN; EXTREMITIES; FEMALE; HUMANS; HYPERTHERMIA, INDUCED; MALE; MELPHALAN; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; SARCOMA; SOFT TISSUE NEOPLASMS; SURVIVAL RATE;

EID: 0030332369     PISSN: 00094722     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001040050132     Document Type: Article

References (23)

1. Brennan MF (1993) Chirurgische Therapie und Prognose des Weichteilsarkoms. Chirurg 64: 449
2. Brennan MF, Casper ES, Harrison LB, Shiu MH, et al (1991) The role of multimodality therapy in soft-tissue sarcoma. Ann Surg 214: 328
3. Creech O, Krementz ET, Ryan RF (1958) Chemotherapy for cancer: regional perfusion utilizing an extracorporal circuit. Ann Surg 148: 616
4. Di Filippo F, Calabro AM, Cavalier F, Piarulli L, Cavaliere R (1988) The role of hyperthermic perfusion as a first step in the treatment of soft tissue sarcoma of the extremities. World J Surg 12: 332
5. Hill S, Fawcett WJ, Sheldon J, Soni N, et al (1993) Low-dose tumor necrosis factor alpha and melphalan in hyperthermic isolated limb perfusion. Br J Surg 80: 995
6. Hoekstra HJ, Schraffordt Koops H (1994) Hyperthermic isolated regional perfusion (HIRP) in the treatment of sarcomas of the extremities. Acta Chir Austriaca 26 [Suppl 108]: 16
7. Hoekstra HJ, Schraffordt Koops H, Molenaar WM, Oldhoff J (1987) Results of isolated regional perfusion in the treatment of malignant soft tissue tumors of the extremities. Cancer 60: 1703
8. Jones AL, Selby P (1989) Clinical applications of tumor necrosis factor. Prog Growth Factor Res 1: 107
9. Klaase JM, Kroon BBR, Benckhuijsen C, van Geel AN, et al (1989) Results of regional perfusion with cytostatics in patients with soft tissue tumors of the extremities. Cancer 64: 616
10. Krementz ET, Carter RD, Sutherland CM, Hutton I (1977) Chemotherapy of sarcomas of the limbs by regional perfusion. Am Surg 185: 555
11. Krementz ET (1986) Regional perfusion, current sophistication, whats next? Cancer 57: 416
12. Lehti PM, Moseley HS, Janoff K, Stevens K, Fletcher WS (1986) Improved survival for soft tissue sarcoma of the extremities by regional hyperthermic perfusion, local excision and radiation therapy. Surg Gynecol Obstet 162: 149
13. Lejeune F, Lienard D, Ewalenko P (1988) Hyperthermic isolation perfusion of the limbs with cytostatics after surgical excision of sarcomas. World J Surg 12: 345
14. Lienard D, Ewalenko P, Delmotte J, Renard N, Lejeune F (1992) High dose recombinant human tumor necrosis factor alpha in combination with interferon gamma and melphalan in isolated perfusion of the limbs for melanoma and sarcoma. J Clin Oncol 10: 52
15. Manner M, Sinn H, Bubeck H, Kettelhack C, Schlag P (1990) Verbesserte intraoperative Leckkontrolle bei der isolierten Zytostatikaperfusion der Extremitäten. Langenbecks Arch Chir 375: 208
16. Moseley SH (1992) An evaluation of two methods of limb salvage in extremity soft-tissue sarcomas. Arch Surg 127: 1169
17. Ruggiero V, Tavernier J, Fiers W, et al (1986) Induction of the synthesis of tumor necrosis factor receptors by interferon gamma. J Immunol 136: 2445
18. Russel W, Cohen J, Enzinger F, Hadjdu S, et al (1977) A clinical and pathological staging system for soft tissue sarcoma. Cancer 40: 1562
19. Schlag PM, Kettelhack Ch (1993) Weichteilsarkome: Die isolierte hypertherme Extremitätenperfusion. Technik und Indikationen. Chirurg 64: 455
20. Stehlin JS, de Ipolyi PD, Giovanella BC, Gutierrez AE, Anderson RF (1975) Soft tissue sarcomas of the extremity: multidisciplinary therapy employing hyperthermic perfusion. Am J Surg 130: 643
21. Stehlin JS, Giovanella BC, de Ipolyi PD, Muenz LR, Anderson RF (1975) Results of hyperthermic perfusion for melanoma of the extremities. Surg Gynecol Obstet 140: 339
22. Wieberdink J, Beckhuysen C, Braat RP, Van Stoolen EA, Olthuis GAA (1982) Dosimetry in isolation perfusion of the limbs by assesment of perfused tissue volume and grading of tissue reactions. Eur J Cancer Clin Oncol 19: 905
23. Willeke F, Lehnen T, Eble M, Schwarzbach M, Herfarth Ch (1994) Therapie fortgeschrittener Sarkome unter besonderer Berücksichtigung der intraoperativen Radiotherapie und der hyperthermen Extremitätenperfusion. Acta Chir Austriaca 26 [Suppl 108]: 22